The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Prospective Study of Coronary Heart Disease Incidence in Relation to Fasting Total Homocysteine, Related Genetic Polymorphisms, and B Vitamins: The Atherosclerosis Risk in Communities (ARIC) Study
Open accessAbstract
Background —Elevated plasma total homocysteine (tHcy), low B-vitamin intake, and genetic polymorphisms related to tHcy metabolism may play roles in coronary heart disease (CHD). More prospective studies are needed. Methods and Results —We used a prospective case-cohort design to determine whether tHcy-related factors are associated with incidence of CHD over an average of 3.3 years of follow-up in a biracial sample of middle-aged men and women. Age-, race-, and field center–adjusted CHD incidence was associated positively ( P <0.05) with tHcy in women but not men, and CHD was associated negatively ( P <0.05) with plasma folate (women only), plasma pyridoxal 5′-phosphate (both sexes), and vitamin supplementation (women only). However, after accounting for other risk factors, only plasma pyridoxal 5′-phosphate was associated with CHD incidence; the relative risk for the highest versus lowest quintile of pyridoxal 5′-phosphate was 0.28 (95% CI=0.1 to 0.7). There was no association of CHD with the C 677 T mutation of the methylenetetrahydrofolate reductase gene or with 3 mutations of the cystathionine β-synthase gene. Conclusions —Our prospective findings add uncertainty to conclusions derived mostly from cross-sectional studies that tHcy is a major, independent, causative risk factor for CHD. Our findings point more strongly to the possibility that vitamin B 6 offers independent protection. Randomized trials, some of which are under way, are needed to better clarify the interrelationships of tHcy, B vitamins, and cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330
Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, G. J. H., den Heijer, M., Kluijtmans, L. A. J., van den Heuve, L. P., et al. (1995) · Nature Genetics · doi:10.1038/ng0595-111 · Cited by 5,653
Reproducibility and validity of a semiquantitative food frequency questionnaire
WILLETT, W. C., SAMPSON, L., STAMPFER, M. J., ROSNER, B., BAIN, C., WITSCHI, J., HENNEKENS, C. H., & SPEIZER, F. E. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114086 · Cited by 4,274
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
Baecke, J., Burema, J., & Frijters, J. (1982) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.936 · Cited by 3,945
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (1957) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,208
(1989) · PubMed · Cited by 3,139
Cardiovascular Survey Methods.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-6-1335_2 · Cited by 3,052
THE ATHEROSCLEROSIS RISK IN COMMUNIT (ARIC) STUDY: DESIGN AND OBJECTIVES
THE ARIC INVESTIGATORS (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115184 · Cited by 2,924
Cited by
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Krauss, R. M., Eckel, R. H., Howard, B., Appel, L. J., Daniels, S. R., Deckelbaum, R. J., Erdman, J. W., Kris-Etherton, P., Goldberg, I. J., Kotchen, T. A., et al. (2000) · Circulation · doi:10.1161/01.cir.102.18.2284 · Cited by 1,458
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., & Rasmussen, K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055227 · Cited by 1,442
Selhub, J. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.217 · Cited by 1,186
Jellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094
Homocysteine and vascular disease
Hankey, G. J., & Eikelboom, J. W. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11058-9 · Cited by 1,052
MTHFR 677C→T Polymorphism and Risk of Coronary Heart Disease: A Meta-analysis
Klerk, M., Verhoef, P., Clarke, R., Blom, H. J., Kok, F. J., Schouten, E. G., & and the MTHFR Studies Collaboration Group (2002) · JAMA · doi:10.1001/jama.288.16.2023 · Cited by 934
Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence
Eikelboom, J. W., Lonn, E., Genest, J., Hankey, G., & Yusuf, S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-5-199909070-00008 · Cited by 908
Krauss, R. M., Eckel, R. H., Howard, B., Appel, L. J., Daniels, S. R., Deckelbaum, R. J., Erdman, J. W., Kris-Etherton, P., Goldberg, I. J., Kotchen, T. A., et al. (2000) · Stroke · doi:10.1161/01.str.31.11.2751 · Cited by 617
Malinow, M. R., Bostom, A. G., & Krauss, R. M. (1999) · Circulation · doi:10.1161/01.cir.99.1.178 · Cited by 586
Self-citationThe ARIC (Atherosclerosis Risk In Communities) Study
Wright, J. D., Folsom, A. R., Coresh, J., Sharrett, A. R., Couper, D., Wagenknecht, L. E., Mosley, T. H., Ballantyne, C. M., Boerwinkle, E. A., Rosamond, W. D., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.035 · Cited by 552
Self-citationJellinger, P. S., Smith, D. A., Mehta, A. E., Ganda, O., Handelsman, Y., Rodbard, H. W., Shepherd, M. D., & Seibel, J. A. (2012) · Endocrine Practice · doi:10.4158/ep.18.s1.1 · Cited by 533
Homocysteine lowering interventions for preventing cardiovascular events
Martí-Carvajal, A. J., Solà, I., Lathyris, D., & Salanti, G. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006612.pub2 · Cited by 520
The controversy over homocysteine and cardiovascular risk
Ueland, P. M., Refsum, H., Beresford, S. A., & Vollset, S. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.324 · Cited by 517
Antioxidants and disease: More questions than answers
Temple, N. J. (2000) · Nutrition Research · doi:10.1016/s0271-5317(00)00138-x · Cited by 466
Polymorphisms in Genes Involved in Folate Metabolism and Colorectal Neoplasia: A HuGE Review
Sharp, L. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh066 · Cited by 442
Homocysteine and cardiovascular disease: cause or effect?
Brattström, L., & Wilcken, D. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.315 · Cited by 439
Homocysteine Level and Coronary Heart Disease Incidence: A Systematic Review and Meta-analysis
Humphrey, L. L., Fu, R., Rogers, K., Freeman, M., & Helfand, M. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.11.1203 · Cited by 396
Inflammation, vitamin B6 and related pathways
Ueland, P. M., McCann, A., Midttun, Ø., & Ulvik, A. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.08.001 · Cited by 382
Helfand, M., Buckley, D. I., Freeman, M., Fu, R., Rogers, K., Fleming, C., & Humphrey, L. L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-7-200910060-00010 · Cited by 382
Hyperhomocysteinemia, Atherosclerosis and Thrombosis
Cattaneo, M. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614438 · Cited by 362
Folsom, A. R., Chambless, L. E., Ballantyne, C. M., Coresh, J., Heiss, G., Wu, K. K., Boerwinkle, E., Mosley, T. H., Sorlie, P., Diao, G., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.13.1368 · Cited by 358
Self-citationNew Risk Factors for Atherosclerosis and Patient Risk Assessment
Fruchart, J.-C., Nierman, M. C., Stroes, E. S. G., Kastelein, J. J. P., & Duriez, P. (2004) · Circulation · doi:10.1161/01.cir.0000131513.33892.5b · Cited by 348
Fasting Plasma Homocysteine Levels in the Insulin Resistance Syndrome
Meigs, J. B., Jacques, P. F., Selhub, J., Singer, D. E., Nathan, D. M., Rifai, N., D’Agostino, R. B., & Wilson, P. W. F. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1403 · Cited by 343
Walsh, B. W., Paul, S., Wild, R. A., Dean, R. A., Tracy, R. P., Cox, D. A., & Anderson, P. W. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6326 · Cited by 326
Evaluating Novel Cardiovascular Risk Factors: Can We Better Predict Heart Attacks?
Ridker, P. M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-11-199906010-00018 · Cited by 323
Vermeulen, E., Stehouwer, C., Twisk, J., van den Berg, M., de Jong, S., Mackaay, A., van Campen, C., Visser, F., Jakobs, C., Bulterijs, E., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)07391-2 · Cited by 322
Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease: Causal or Casual?
Christen, W. G., Ajani, U. A., Glynn, R. J., & Hennekens, C. H. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.422 · Cited by 304
Risk factors for coronary heart disease: implications of gender
Roeters van Lennep, J. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00388-1 · Cited by 300
Folates and Cardiovascular Disease
Verhaar, M. C., Stroes, E., & Rabelink, T. J. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0102.102190 · Cited by 291
Homocysteine and cardiovascular disease: a review of the evidence
Wierzbicki, A. S. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.033 · Cited by 287
De Bree, A., Verschuren, W. M. M., Kromhout, D., Kluijtmans, L. A. J., & Blom, H. J. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.599 · Cited by 282
Hoogeveen, E. K., Kostense, P. J., Jakobs, C., Dekker, J. M., Nijpels, G., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A. (2000) · Circulation · doi:10.1161/01.cir.101.13.1506 · Cited by 273
Tucker, K. L., Qiao, N., Scott, T., Rosenberg, I., & Spiro, A. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.3.627 · Cited by 351
Folate, homocysteine, endothelial function and cardiovascular disease
Moat, S. J., Lang, D., McDowell, I. F. W., Clarke, Z. L., Madhavan, A. K., Lewis, M. J., & Goodfellow, J. (2004) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2003.08.010 · Cited by 261
Impaired Homocysteine Metabolism and Atherothrombotic Disease
Durand, P., Prost, M., Loreau, N., Lussier-Cacan, S., & Blache, D. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780275 · Cited by 261
Total homocysteine and cardiovascular disease
Nygård, O., Vollset, S. E., Refsum, H., Brattström, L., & Ueland, P. M. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00512.x · Cited by 256
Harmon, D. L., Shields, D. C., Woodside, J. V., McMaster, D., Yarnell, J. W. G., Young, I. S., Peng, K., Shane, B., Evans, A. E., & Whitehead, A. S. (1999) · Genetic Epidemiology · doi:10.1002/(sici)1098-2272(199911)17:4<298::aid-gepi5>3.0.co;2-v · Cited by 256
Homocysteine and Risk of Cardiovascular Disease Among Postmenopausal Women
Ridker, P. M. (1999) · JAMA · doi:10.1001/jama.281.19.1817 · Cited by 253
Serum Folate and Cardiovascular Disease Mortality Among US Men and Women
Loria, C. M., Ingram, D. D., Feldman, J. J., Wright, J. D., & Madans, J. H. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3258 · Cited by 98
da Luz, P. L., Bertini, P. J., & Favarato, D. (2005) · Clinics · doi:10.1590/s1807-59322005000500011 · Cited by 13
Metadata
- Authors
- Folsom, A. R., Nieto, F. J., McGovern, P. G., Tsai, M. Y., Malinow, M. R., Eckfeldt, J. H., Hess, D. L., & Davis, C. E.
- Venue
- Circulation
- Published
- 1998-07-21
- Volume
- 98
- Issue
- 3
- Pages
- 204-210
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2010202776
- Cited by
- 603
- References
- 48
- FWCI
- 46.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.